Retapamulin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Retapamulinum

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antibiotic from the pleuromutiline group.

Pharmacodynamics (Effect)This section has been translated automatically.

Inhibition of protein synthesis by binding to the 50s subunit of the 70s ribosomes of bacteria.

Spectrum of actionThis section has been translated automatically.

Retapamulin has a bacteriostatic effect against Staphylococcus aureus and Streptococcus pyogenes by inhibiting bacterial protein synthesis via ribosomal binding. The binding site is different from other antibiotics. It is not effective against Gram-negative bacteria (e.g. Escherichia coli and Haemophilus influenzae).

IndicationThis section has been translated automatically.

Approved for topical treatment of impetigo and other skin infections from the age of 9 months.

Dosage and method of useThis section has been translated automatically.

Cream 1%: Apply 2 times/day, use for 5 days

Standard concentrationThis section has been translated automatically.

1% cream

PreparationsThis section has been translated automatically.

Altargo®

LiteratureThis section has been translated automatically.

  1. Rittenhouse S et al (2006) Selection of retapamulin, a novel pleuromutilin for topical use. Antimicrob Agents Chemother 50: 3882-3885

Authors

Last updated on: 29.10.2020